Scientific forums/special focus groups

Wednesday, February 4, 2004
        Math EqMath EqMath Eq
        Computers Rosedown 3:00 pm
        Critical Care Magnolia 3:00 pm
        Diabetes Eglinton Winton 3:00 pm
        Fetal Surgery Belle Chasse 3:00 pm
        Genetics Elmwood 3:00 pm
        Hypertension Oak Alley 3:00 pm
        Infectious Diseases Melrose 3:00 pm
        Perinatal Epidemiology Newberry 3:00 pm
        Prematurity Versailles 3:00 pm
        Ultrasound Napoleon 3:00 pm
        THURSDAY, FEBRUARY 5, 2004
        Women In Perinatology 11:30 am–1:00 pm Belle Chasse
        Special Focus Group Box Lunch
        Research Support Personnel 11:30 am–1:00 pm Rosedown
        Special Focus Group Box Lunch Meeting
        International Society of Perinatal 5:30 pm–7:30 pm Oak Alley
        Obstetricians Scientific Forum
        FRIDAY, FEBRUARY 6, 2004
        ISPO Breakfast Meeting 7:00 am–8:00 am Rosedown
        Math Eq
        Pro-Life MFMs (Check with the Meeting Registration Desk for specific date, time, and location.)
        Society for Maternal-Fetal Medicine 2004 Meeting New Orleans, LA
        Wednesday, February 4, 2004
        Computers in Maternal-Fetal Medicine 3:00pm-6:00pm
        Leader: Andrzej J. Lysikiewicz, MD
        • I.
          Internet and Maternal-Fetal Medicine
          • Practicing MFM on the Internet
          • Information
            • For patients
            • For physicians
          • Teaching on the net (residents/fellows)
        • II.
          New Technologies
          • PDA/Pocket PC applications
          • Telemedicine
          • Computer imaging for MFM
          • Computer data management
        • III.
          Specific computer applications
          • Artificial intelligence
          • Fetal heart rate evaluation with computer
          • Ultrasound and computers
        • IV.
          Open forum
        Critical Care in Obstetrics 3:00pm-5:00pm
        Leader: Stephanie R. Martin, DO
        • I.
          Introduction and Welcome to Participants
        • II.
          Case presentation by Physician-in-Training followed by Discussion/presentations by Attending Physicians
          • A.
            Monique Lin, MD (30 minutes)
            • Senior Resident, OB/GYN
            • Good Samaritan Regional Medical Center
            • Phoenix, AZ
            • Stephanie R. Martin, DO (30 minutes)
            • Associate Director, Maternal Fetal Medicine
            • Phoenix Perinatal Associates
          • B.
            Luis Pacheco, MD (30 minutes)
            • University of Texas Medical Branch
            • Galveston, TX
            • Alfredo Gei, MD (30 minutes)
            • University of Texas Medical Branch
            • Galveston, TX
          • C.
            Offer Erez, MD
            • Department of OB/GYN
            • Soroka University Medical Center
            • Ben Gurion University of the Negev
            • Beer-Sheva, Israel
        • III.
          Conclusion / Closing Remarks: Stephanie R. Martin, DO
        Diabetes 3:00pm-5:20pm
        Leader: David A. Sacks, MD
        • I.
          Greetings and Announcements 3:00pm-3:10pm
          • David Sacks, MD
        • II.
          The Role of Nutrition and Diabetes
          • Associated with Birth Defects 3:10pm-3:40pm
            • E. Albert Reece, MD, PhD, MBA
            • University of Arkansas
        • III.
          The Use and Misuse of Guidelines for GDM Screening 3:40pm-4:10pm
          • Dan Farine, MD
          • Mt. Sinai Hospital/University of Toronto
        • IV.
          Calcium Channel Blockers for Pregnant Diabetic Women 4:10pm-4:40pm
          • Siri L. Kjos, MD
          • University of Southern California
        • V.
          Closing the Loop: The Development of an Artificial Beta Cell 4:40pm-5:10pm
          • Lois B. Jovanonvic, MD
          • Sansum Medical Research Institute
        Selection of a New Group Leader 5:10pm-5:20pm
        Fetal Surgery 3:00pm-6:00pm
        Leader: Joseph Bruner, MD
        • I.
          Fetal Valvuloplasty
          • Left-sided lesions Wayne Tworetsky, MD (Boston, MA)
          • Right-sided lesions Helena Gardiner, MD (London, England)
          • Is fetal valvuloplasty justified? Josh Copel, MD (New Haven, CT)
        • II.
          Twin-Twin Transfusion Syndrome
          • Results of the Eurofetus Trial Yves Ville, MD (Paris, France)
          • The NIH TTTS Trial Robert Ball, MD (San Francisco, CA)
          • International TTTS Trial Ruben Quintero, MD (Tampa, FL)
          • Do we need more TTTS trials? Cathy Spong, MD (Washington, DC)
        • III.
          Congenital Diaphragmatic Hernia
          • The European pilot study Jan Deprest, MD (Leuven, Belgium)
          • Is fetal surgery for CDH justified? Alan Flake, MD (Philadelphia, PA)
        • IV.
          Spina Bifida
          • MOMS Trial update Nancy Chescheir, MD (Chapel Hill, NC)
        • V.
          Amnioexchange for Gastroschisis
          • Collaborative randomized trial Joe Bruner, MD (Nashville, TN)
        Genetics 3:00pm-6:00pm
        Leader: George Henry, MD
        Information not available at press time.
        Hypertension in Pregnancy 3:00pm-6:00pm
        Leader: Chaur-Dong Hsu, MD, MPH
        • I.
          Debate: Should women with severe preeclampsia be screened for thrombophilia?
          • Yes: Michael Kupferminc, MD
            • Head, Division of Maternal Fetal Medicine
            • Department of Obstetrics & Gynecology
            • Tel Aviv Medical Center
            • Tel Aviv, Israel
          • No: Baha M. Sibai, MD
            • Chair, Department of Obstetrics & Gynecology
            • University of Cincinnati College of Medicine
            • Cincinnati, Ohio
          • Questions and Answers
        • II.
          Angiogenesis and Preeclampsia: Clinical Aspects and Laboratory Investigation
          Introduction:Richard J. Levine, MD
          Laboratory Investigation: S. Ananth Karumanchi, MD
          Assistant Professor of Medicine
          Beth Israel Deaconess Medical Center and Harvard Medical School
          Boston, Massachusetts
          Clinical Aspects: Roberto Romero, MD
          Chief, Perinatology Research Branch
          Intramural Division
          NICHD, NIH, DHHS
          Bethesda, Maryland/Detroit, Michigan
          Questions and Answers
        • III.
          North American Society for the Study of Hypertension in Pregnancy
        Business Meeting: Thomas R. Easterling, MD, President
        Infectious Disease 3:00pm-5:00pm
        Leader: Kim A. Boggess, MD
        • I.
          Antibiotic Use in Obstetrics
          • Brian Mercer, MD
          • Director, General Clinic Research Center
          • Professor and Director, Maternal-Fetal Medicine
          • Cleveland, OH
        • II.
          Group B Streptococcus Post New CDC Guidelines and Beyond
          • Carol Baker, MD
          • Professor and Head, Pediatric Infectious Diseases
          • Dept. of Pediatrics
          • Baylor College of Medicine
          • Houston, TX
        • III.
          Role of Genital Tract Immunity During Pregnancy
          • Alice Goepfert, MD
          • Assistant Professor
          • Dept of Obstetrics and Gynecology
          • University of Alabama
          • Birmingham, AL
        Perinatal Epidemiology 3:00pm-5:00pm
        Leaders: George Macones, MD and David Stamilio, MD, MSCE
        Topic: Perinatal Risk Assessment and Risk Scoring
        Description: This scientific forum will outline the basics of risk assessment in perinatal research and present the finer points of perinatal risk assessment, risk scoring and clinical prediction as they apply to perinatal medicine. The forum attendees will review the concept and representation of risk, learn methods of developing risk assessment systems and clinical prediction rules, learn specific methodological problems in applying risk assessment systems, and become familiar with the use of artificial intelligence in perinatal risk assessment. Lectures will focus more on epidemiologic methods and clinical applications rather than biostatistical analysis.
        Moderator: David Stamilio, MD, MSCE, University of Pennsylvania Medical Center and Center for Clinical Epidemiology and Biostatistics, Philadelphia, PA.
        • I.
          “The Evaluation of Risk in Perinatal Epidemiology.”
          • Anthony O. Odibo, MD, MRCOG
          • University of Pennsylvania Medical Center, Philadelphia, PA
        • II.
          “Methodological Issues in Developing and Applying Risk Assessment Systems in Perinatal Research and Medicine.”
          • Jun Zhang
          • NIH/NICHD, Bethesda, MD
        • III.
          “Applications of Artificial Intelligence (Neural Networks) in Perinatal Risk Assessment.”
          • George A. Macones, MD, MSCE
          • University of Pennsylvania Medical Center and Center for Clinical Epidemiology and Biostatistics, Philadelphia, PA
        Preterm Labor 3:00pm-5:00pm
        Leader: Vincenzo Berghella, MD
        Title: Progesterone for prevention of preterm birth
        • I.
          Introduction 3:00pm-3:10pm
          • Vincenzo Berghella, MD
          • Thomas Jefferson University
          • Philadelphia, PA
        • II.
          Why would progesterone work to prevent prematurity? 3:10pm-3:30pm
          • Michal Elovitz, MD
          • University of Pennsylvania
          • Philadelphia, PA
        • III.
          Details of the NICHD Progesterone Trial 3:30pm-3:50pm
          • Paul Meis, MD
          • Wake Forest
          • Winston-Salem, North Carolina
        • IV.
          Evidence-based Review of the Literature  3:50pm-4:10pm
          • Marc Keirse, MD
          • The Flinders University of South Australia,
          • Adelaide, Australia
        • V.
          Implications for current clinical practice and future research 4:10pm-4:30pm
          • Steve Caritis, MD
          • University of Pittsburgh
          • Pittsburgh, Pennsylvania
        • VI.
          Discussion 4:30pm-5:00pm
        Ultrasound 3:00pm-6:00pm
        Leader: Ana Monteagudo, MD
        Title: The ‘New’ Ultrasound Marker for Fetal Aneuploidy: The Nasal Bone
        Over the past decade a variety of sonographic markers for fetal aneuploidy have been introduced; some of these markers have likelihood ratios so low that they have not been very helpful. However, the nasal bone, the newest sonographic marker of fetal aneuploidy, seems to have a high likelihood ratio, making it the most powerful marker to date.
        This forum will discuss the current accumulated knowledge regarding the evaluation of the fetal nasal bone by ultrasound.
        • I.
          • Ana Monteagudo, MD
        • II.
          Nasal bone a marker for fetal aneuploidy. A review of the world's experience
          • J. D. Sonek, MD
        • III.
          Evaluation of the fetal nasal bone during the second trimester of pregnancy
          • J. D. Sonek, MD
        Other speakers: TBA
        Thursday, February 5
        International Society of Perinatal Obstetricians 5:30pm-7:30pm
        President: Benjamin Chayen, MD
        Scientific Sessions
        Friday, February 6
        International Society of Perinatal Obstetricians 7:00am-8:00am
        Breakfast Meeting
        Special Focus Groups
        Thursday, February 5
        Women in Perinatology11:30am-1:00pm
        Leader: Jessica Bienstock, MD
        Box Lunch Meeting
        Topic: What Successful Negotiators Do!—Frank J. Haluch
        Women physicians often feel that they lack sufficient skills to negotiate for what they need or want at work. The focus of this lunch will be learning the key behaviors of skilled negotiators. Successful negotiators know they must manage time, information, and power to reach their goals. They have a plan for reaching their goals, not just a dream. They know how to increase their power and use their power to influence decision making. They know how to negotiate concessions. You will see an actual negotiation in which these principals are demonstrated.
        During this session participants will learn the ten key behaviors of skilled negotiators, five simple words that will improve their negotiation effectiveness, and seven important concession rules.
        About Frank J. Haluch
        Frank began negotiating multimillion dollar contracts almost from the day he joined GE in 1967. In 1983 he began leading seminars in negotiations for GE management professionals. In 1988 he founded Haluch & Associates Ltd. with GE as his sole client. Since then, his client base has grown to include AlliedSignal, American Airlines, American Standard Companies, Brunswick Corporation, Deere & Company, Delta Air Lines, Bristol-Myers Squibb, Ingersoll-Rand, James River, and Otis Elevator. GE is still a client.
        Frank has participated in the delivery of executive seminars at the American Graduate School of International Management, Arizona State University, and Lehigh University; has written chapters on negotiations for professional handbooks; and has been quoted in a number of textbooks. Haluch & Associates Ltd. conducts negotiations seminars across the United States and in Mexico, Europe, South America, Asia, and Africa.
        Research Support Personnel 11:30am-1:00pm
        Leader: Karen Dorman
        Box Lunch Meeting
        Information not available at press time.